Trial Profile
Safety and efficacy of ultra-long everolimus-eluting stent implantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- 22 Dec 2015 New trial record